AGC (5201) IR Day 2024 Day 2 summary
Event summary combining transcript, slides, and related documents.
IR Day 2024 Day 2 summary
31 Jan, 2026Financial targets and capital allocation
Aims to achieve ROE of 8% by 2026 and 10% by 2030, requiring JPY 300 billion in operating profit by 2030.
Group-wide ROCE target is 10% or higher, with operating profit targeted at JPY 230 billion by 2026 and strategic business OP at JPY 130 billion or more.
Strategic investment budget set at JPY 200 billion for growth businesses, with capital allocation prioritizing strategic business investment, stable dividends, and selective share buybacks.
Dividend payouts will rise compared to the previous midterm plan, with share buybacks considered if surplus capital remains.
D/E ratio to be kept at 0.5 or less, and EBITDA to reach JPY 440 billion by 2026.
Chemicals business strategy and outlook
Essential Chemicals will focus on Southeast Asia, expanding chlor-alkali and PVC capacity, aiming for over 50% market share post-expansion.
Performance Chemicals targets growth in semiconductor and hydrogen markets, with semiconductor/hydrogen sales to rise from 5% to 20% by 2030.
ROCE targets: 10% for Essential Chemicals, 20%+ for Performance Chemicals, with operating profit goal of JPY 86 billion in 2026.
PFAS regulations pose a challenge, but most problematic substances have been eliminated from products.
Demand for chlor-alkali in Southeast Asia expected to grow long-term, driven by regional economic development.
Electronics business strategy and performance
Electronics sales reached JPY 313.2 billion in 2023, with Display segment recovering and Electronic Materials showing steady growth.
Display business is undergoing structural reform, reducing capacity by 20% by end-2024 and focusing on large panel substrates.
Electronic Materials segment leverages both organic/inorganic materials, with strong positions in EUV mask blanks, CMP slurry, and IR cutoff filters.
EUV mask blanks sales target of JPY 40 billion, originally set for 2025, is expected to be achieved in 2024 due to strong demand.
2026 targets: JPY 380 billion net sales, JPY 53 billion operating profit, and 10% ROCE for Electronics.
Latest events from AGC
- Operating profit and ROE improved; FY2026 targets higher growth led by Life Science recovery.5201
Q4 20256 Feb 2026 - 8% ROE and 440bn yen EBITDA targeted for 2026 via transformation and disciplined investment.5201
IR Day 2024 Day 131 Jan 2026 - Operating and net profit improved despite lower sales, with stable outlook and dividends.5201
Q3 20255 Nov 2025 - Targets net zero carbon by 2050, driven by innovation, ESG, and talent development.5201
ESG Update26 Sep 2025 - FY2025 outlook cut as Chemicals, Life Science, and Electronics underperform; profit rebounds.5201
Q2 20251 Aug 2025 - Global leader in glass, chemicals, and life sciences, driving innovation and sustainable growth.5201
Corporate Presentation7 Jul 2025 - Ambidextrous strategy and sustainability drive growth, digitalization, and profitability targets.5201
Company Presentation7 Jul 2025 - Life Science impairments and Russian exit led to a sharp H1 2024 net loss despite sales growth.5201
Q2 202413 Jun 2025 - Sales rose, but major impairments and Russian exit drove a sharp net loss.5201
Q3 202413 Jun 2025